In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Immuneering Corp (NASDAQ: IMRX) was $8.0 for the day, down -13.33% from the previous closing price of $9.23. In other words, the price has decreased by -$13.33 from its previous closing price. On the day, 20.93 million shares were traded. IMRX stock price reached its highest trading level at $9.6 during the session, while it also had its lowest trading level at $7.25.
Ratios:
Our analysis of IMRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.70 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 15, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $20 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 23 ’25 when BERMAN ANN E bought 14,000 shares for $9.72 per share.
HAUSMAN DIANA bought 3,000 shares of IMRX for $10,874 on Jul 02 ’25. The Director now owns 3,000 shares after completing the transaction at $3.62 per share. On Jul 02 ’25, another insider, HAUSMAN DIANA, who serves as the Director of the company, bought 2,500 shares for $3.60 each. As a result, the insider paid 8,989 and bolstered with 2,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 383693184 and an Enterprise Value of 268196080.
Stock Price History:
The Beta on a monthly basis for IMRX is 0.52, which has changed by 2.0075188 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, IMRX has reached a high of $10.08, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 50.22%, while the 200-Day Moving Average is calculated to be 185.66%.
Shares Statistics:
IMRX traded an average of 1.03M shares per day over the past three months and 3604640 shares per day over the past ten days. A total of 35.99M shares are outstanding, with a floating share count of 29.76M. Insiders hold about 28.41% of the company’s shares, while institutions hold 9.21% stake in the company. Shares short for IMRX as of 1756425600 were 1830280 with a Short Ratio of 2.88, compared to 1753920000 on 1555893. Therefore, it implies a Short% of Shares Outstanding of 1830280 and a Short% of Float of 5.3600002.
Earnings Estimates
The market rating for Immuneering Corp (IMRX) is a result of the insights provided by 5.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.21 and low estimates of -$0.78.
Analysts are recommending an EPS of between -$1.29 and -$2.25 for the fiscal current year, implying an average EPS of -$1.65. EPS for the following year is -$1.64, with 5.0 analysts recommending between -$0.74 and -$2.17.
